{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:35:21Z","timestamp":1792222521094,"version":"4.4.0"},"reference-count":335,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific Research at Al-Zaytoonah University of Jordan","award":["2020-2019\/17\/03"],"award-info":[{"award-number":["2020-2019\/17\/03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Despite the great technological and medical advances in fighting viral diseases, new therapies for most of them are still lacking, and existing antivirals suffer from major limitations regarding drug resistance and a limited spectrum of activity. In fact, most approved antivirals are directly acting antiviral (DAA) drugs, which interfere with viral proteins and confer great selectivity towards their viral targets but suffer from resistance and limited spectrum. Nowadays, host-targeted antivirals (HTAs) are on the rise, in the drug discovery and development pipelines, in academia and in the pharmaceutical industry. These drugs target host proteins involved in the virus life cycle and are considered promising alternatives to DAAs due to their broader spectrum and lower potential for resistance. Herein, we discuss an important class of HTAs that modulate signal transduction pathways by targeting host kinases. Kinases are considered key enzymes that control virus-host interactions. We also provide a synopsis of the antiviral drug discovery and development pipeline detailing antiviral kinase targets, drug types, therapeutic classes for repurposed drugs, and top developing organizations. Furthermore, we detail the drug design and repurposing considerations, as well as the limitations and challenges, for kinase-targeted antivirals, including the choice of the binding sites, physicochemical properties, and drug combinations.<\/jats:p>","DOI":"10.3390\/v15020568","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T04:58:23Z","timestamp":1676869103000},"page":"568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-5425","authenticated-orcid":false,"given":"Rima","family":"Hajjo","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan"},{"name":"Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carlina at Chapel Hill, Chapel Hill, NC 27599, USA"},{"name":"Jordan CDC, Amman 11118, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-5097","authenticated-orcid":false,"given":"Dima A.","family":"Sabbah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-5618","authenticated-orcid":false,"given":"Osama H.","family":"Abusara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Kharmah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman 11733, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-0708","authenticated-orcid":false,"given":"Sanaa","family":"Bardaweel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,19]]},"reference":[{"key":"ref_1","unstructured":"Li, G., and De Clercq, E. (2021). Antiviral Discovery for Highly Pathogenic Emerging Viruses, The Royal Society of Chemistry."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1568026620666201207095117","article-title":"An Updated Review on SARS-CoV-2 Main Proteinase (M(Pro)): Protein Structure and Small-Molecule Inhibitors","volume":"21","author":"Sabbah","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s11033-021-06390-1","article-title":"Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges","volume":"48","author":"Mahmoud","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.idc.2010.01.001","article-title":"Antiviral drug resistance: Mechanisms and clinical implications","volume":"24","author":"Strasfeld","year":"2010","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/dmp.2020.437","article-title":"Conducting COVID-19-Related Research in Jordan: Are We Ready?","volume":"16","author":"Ikhmais","year":"2022","journal-title":"Disaster Med. Public Health Prep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/095632020601700601","article-title":"Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs","volume":"17","author":"Schang","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_8","unstructured":"Richman, D.D., and Nathanson, N. (2016). Viral Pathogenesis, Elsevier."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2006.03.004","article-title":"Antiviral drug resistance","volume":"71","author":"Richman","year":"2006","journal-title":"Antiviral Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1568026621666210119111409","article-title":"An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery","volume":"21","author":"Sabbah","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4614-0980-9_3","article-title":"Principles of virus structural organization","volume":"726","author":"Prasad","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Khirfan, F., Jarrar, Y., Al-Qirim, T., Goh, K.W., Jarrar, Q., Ardianto, C., Awad, M., Al-Ameer, H.J., Al-Awaida, W., and Moshawih, S. (2022). Analgesics Induce Alterations in the Expression of SARS-CoV-2 Entry and Arachidonic-Acid-Metabolizing Genes in the Mouse Lungs. Pharmaceuticals, 15.","DOI":"10.3390\/ph15060696"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-444-53488-0.00002-X","article-title":"Basics of virology","volume":"123","author":"Pellett","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Liu, Y., Dyall-Smith, M., and Oksanen, H.M. (2022). ICTV Virus Taxonomy Profile: Pleolipoviridae 2022. J. Gen. Virol., 103.","DOI":"10.1099\/jgv.0.001793"},{"key":"ref_15","unstructured":"King, A.M., Lefkowitz, E., Adams, M.J., and Carstens, E.B. (2011). Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier."},{"key":"ref_16","unstructured":"ICTV (2022, December 02). About Virus Taxonomic Classification. Available online: https:\/\/ictv.global\/taxonomy\/about."},{"key":"ref_17","unstructured":"ICTV (2022, December 02). Current ICTV Taxonomy Release. Available online: https:\/\/ictv.global\/taxonomy."},{"key":"ref_18","unstructured":"ICTV (2022, December 02). ICTV Report Chapters by Genome. Available online: https:\/\/ictv.global\/report\/genome."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/br.35.3.235-241.1971","article-title":"Expression of animal virus genomes","volume":"35","author":"Baltimore","year":"1971","journal-title":"Bacteriol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.2164-0947.1971.tb02600.x","article-title":"Viral genetic systems","volume":"33","author":"Baltimore","year":"1971","journal-title":"Trans. N. Y. Acad. Sci."},{"key":"ref_21","first-page":"57","article-title":"The strategy of RNA viruses","volume":"70","author":"Baltimore","year":"1974","journal-title":"Harvey Lect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e0005321","DOI":"10.1128\/MMBR.00053-21","article-title":"The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?","volume":"85","author":"Koonin","year":"2021","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2478\/acph-2021-0013","article-title":"Sitagliptin: A potential drug for the treatment of COVID-19?","volume":"71","author":"Bardaweel","year":"2021","journal-title":"Acta Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coviro.2011.06.002","article-title":"Cell entry of enveloped viruses","volume":"1","author":"Plemper","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.1073\/pnas.0501864102","article-title":"Imaging individual retroviral fusion events: From hemifusion to pore formation and growth","volume":"102","author":"Melikyan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-12-380860-8.00004-5","article-title":"Cell entry of enveloped viruses","volume":"73","author":"Cosset","year":"2011","journal-title":"Adv. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1091\/mbc.11.4.1143","article-title":"The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores","volume":"11","author":"Markosyan","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1083\/jcb.140.6.1369","article-title":"The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation","volume":"140","author":"Chernomordik","year":"1998","journal-title":"J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.virol.2003.07.006","article-title":"Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement","volume":"316","author":"Peeples","year":"2003","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2011.05.002","article-title":"Viral weapons of membrane destruction: Variable modes of membrane penetration by non-enveloped viruses","volume":"1","author":"Moyer","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coviro.2012.12.004","article-title":"Uncoating of non-enveloped viruses","volume":"3","author":"Suomalainen","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.virol.2015.01.024","article-title":"DNA virus uncoating","volume":"479\u2013480","author":"Kilcher","year":"2015","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/jvi.41.1.51-65.1982","article-title":"Nucleotide sequence of a cloned woodchuck hepatitis virus genome: Comparison with the hepatitis B virus sequence","volume":"41","author":"Galibert","year":"1982","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virusres.2007.02.021","article-title":"Hepatitis B virus genetic variability and evolution","volume":"127","author":"Kay","year":"2007","journal-title":"Virus Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rampersad, S., and Tennant, P. (2018). Replication and Expression Strategies of Viruses. Viruses, 55\u201382.","DOI":"10.1016\/B978-0-12-811257-1.00003-6"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/MMBR.00049-13","article-title":"Virus world as an evolutionary network of viruses and capsidless selfish elements","volume":"78","author":"Koonin","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_37","first-page":"125","article-title":"Chapter 9\u2014CDK Inhibitors as Sensitizing Agents for Cancer Chemotherapy","volume":"Volume 4","author":"Chen","year":"2019","journal-title":"Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1021\/acsomega.0c03597","article-title":"Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19","volume":"5","author":"Hajjo","year":"2020","journal-title":"ACS Omega"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hajjo, R., Sabbah, D.A., Bardaweel, S.K., and Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9.","DOI":"10.3390\/vaccines9101186"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bioorg.2011.07.004","article-title":"Protein kinase biochemistry and drug discovery","volume":"39","author":"Schwartz","year":"2011","journal-title":"Bioorg. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/acs.jmedchem.1c00302","article-title":"Kinase Inhibitors as Underexplored Antiviral Agents","volume":"65","author":"Caballero","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases--the major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2017.10.010","article-title":"Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement","volume":"25","author":"Vasta","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrg2707","article-title":"Kinase mutations in human disease: Interpreting genotype-phenotype relationships","volume":"11","author":"Lahiry","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"ra98","DOI":"10.1126\/scisignal.aaf5132","article-title":"Quantitative phosphoproteomic analysis identifies the critical role of JNK1 in neuroinflammation induced by Japanese encephalitis virus","volume":"9","author":"Ye","year":"2016","journal-title":"Sci. Signal."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41467-018-06119-y","article-title":"Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target","volume":"9","author":"Hunziker","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_48","first-page":"103","article-title":"The cell cycle, cyclin-dependent kinases, and viral infections: New horizons and unexpected connections","volume":"5","author":"Schang","year":"2003","journal-title":"Prog. Cell Cycle Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-0888-2_10","article-title":"Cell cycle regulation during viral infection","volume":"1170","author":"Bagga","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tim.2021.01.014","article-title":"Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics","volume":"29","author":"Felip","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"re2","DOI":"10.1126\/stke.2001.89.re2","article-title":"Signal integration via PKR","volume":"2001","author":"Williams","year":"2001","journal-title":"Sci. STKE"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jir.2010.0099","article-title":"The role of protein kinase R in the interferon response","volume":"31","author":"Pindel","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"24946","DOI":"10.1074\/jbc.M102108200","article-title":"Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.celrep.2016.12.045","article-title":"Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses","volume":"18","author":"Meertens","year":"2017","journal-title":"Cell Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"104651","DOI":"10.1016\/j.antiviral.2019.104651","article-title":"Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways","volume":"173","author":"Dong","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2018.05.028","article-title":"Role of MAPK\/MNK1 signaling in virus replication","volume":"253","author":"Kumar","year":"2018","journal-title":"Virus Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1128\/MCB.22.4.1001-1015.2002","article-title":"Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses","volume":"22","author":"Katagiri","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ja\u015bkiewicz, A., Paj\u0105k, B., and Orzechowski, A. (2018). The Many Faces of Rap1 GTPase. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102848"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fonc.2014.00167","article-title":"Activated ras signaling pathways and reovirus oncolysis: An update on the mechanism of preferential reovirus replication in cancer cells","volume":"4","author":"Gong","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kleinehr, J., Wilden, J.J., Boergeling, Y., Ludwig, S., and Hrincius, E.R. (2021). Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets. Viruses, 13.","DOI":"10.3390\/v13102068"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/22221751.2020.1799723","article-title":"Dysregulation in Akt\/mTOR\/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells","volume":"9","author":"Appelberg","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/13543776.2021.1924150","article-title":"Phosphatidylinositol 3-kinase (PI3K) inhibitors: A recent update on inhibitor design and clinical trials (2016\u20132020)","volume":"31","author":"Sabbah","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_65","unstructured":"Garbe, C., and Zibert, J. (2013). Ingenol mebutate gel, 0.015% repeat use for Multiple Actinic Keratoses on face and scalp: A review of the phase 3 clinical study rationale and design. J. Dtsch. Dermatol. Ges., 131."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Solares, A.M., Santana, A., Baladr\u00f3n, I., Valenzuela, C., Gonz\u00e1lez, C.A., D\u00edaz, A., Castillo, D., Ramos, T., G\u00f3mez, R., and Alonso, D.F. (2009). Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-146"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14312\/2052-4994.2013-25","article-title":"Pharmacological and safety evaluation of CIGB-300, a casein kinase 2 inhibitor peptide, administered intralesionally to patients with cervical cancer stage IB2\/II","volume":"1","author":"Pedro","year":"2013","journal-title":"J. Cancer Res. Ther."},{"key":"ref_68","unstructured":"Pass, H.I., Ball, D., and Scagliotti, G.V. (2018). IASLC Thoracic Oncology, Elsevier. [2nd ed.]."},{"key":"ref_69","unstructured":"(2022, November 21). Identifier: NCT04480957. Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04480957."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ygyno.2007.08.074","article-title":"Phase I\/II clinical safety studies of terameprocol vaginal ointment","volume":"107","author":"Khanna","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","article-title":"A comprehensive review of the global efforts on COVID-19 vaccine development","volume":"7","author":"Li","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/1568026054985911","article-title":"Potential adverse effects associated with inhibition of p38\u03b1\/\u03b2 MAP kinases","volume":"5","author":"Dambach","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1473-3099(20)30262-0","article-title":"Baricitinib for COVID-19: A suitable treatment?","volume":"20","author":"Favalli","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1006\/jmbi.1999.2640","article-title":"Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors","volume":"287","author":"Pavletich","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1101\/gad.851100","article-title":"Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors","volume":"14","author":"Jeffrey","year":"2000","journal-title":"Genes Dev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fcimb.2018.00396","article-title":"Breaking Bad: How Viruses Subvert the Cell Cycle","volume":"8","author":"Fan","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: A critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Peyressatre, M., Pr\u00e9vel, C., Pellerano, M., and Morris, M.C. (2015). Targeting cyclin-dependent kinases in human cancers: From small molecules to Peptide inhibitors. Cancers, 7.","DOI":"10.3390\/cancers7010179"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-6405-7-7","article-title":"Inhibition of human immunodeficiency virus type-1 by cdk inhibitors","volume":"7","author":"Guendel","year":"2010","journal-title":"AIDS Res. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication","volume":"13","author":"Perwitasari","year":"2015","journal-title":"Assay. Drug Dev. Technol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2016.08.008","article-title":"Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation","volume":"133","author":"Tanaka","year":"2016","journal-title":"Antiviral Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e00819-20","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/acscombsci.0c00140","article-title":"Profiling SARS-CoV-2 Main Protease (M(PRO)) Binding to Repurposed Drugs Using Molecular Dynamics Simulations in Classical and Neural Network-Trained Force Fields","volume":"22","author":"Gupta","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"ref_86","first-page":"rs-25643","article-title":"Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS","volume":"rs.3","author":"Eby","year":"2020","journal-title":"Res. Sq."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","article-title":"Controlling the elongation phase of transcription with P-TEFb","volume":"23","author":"Peterlin","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","article-title":"A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA","volume":"92","author":"Wei","year":"1998","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570162052772924","article-title":"HIV-1 TAR RNA: The target of molecular interactions between the virus and its host","volume":"3","author":"Bannwarth","year":"2005","journal-title":"Curr. HIV Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/MCB.20.8.2629-2634.2000","article-title":"P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II","volume":"20","author":"Price","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hajjo, R., Sabbah, D.A., and Tropsha, A. (2022). Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects. Pathogens, 11.","DOI":"10.3390\/pathogens11070743"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.2164259","article-title":"An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control","volume":"249","author":"Boulton","year":"1990","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","article-title":"Differential regulation and properties of MAPKs","volume":"26","author":"Raman","year":"2007","journal-title":"Oncogene"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2009.10.019","article-title":"JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol","volume":"396","author":"Medina","year":"2010","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bjid.2012.11.009","article-title":"Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells","volume":"17","author":"Shi","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions","volume":"68","author":"Roux","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: From signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"Ra148","DOI":"10.12659\/MSM.881801","article-title":"Influenza virus and cell signaling pathways","volume":"17","author":"Gaur","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1462-5822.2005.00678.x","article-title":"Ringing the alarm bells: Signalling and apoptosis in influenza virus infected cells","volume":"8","author":"Ludwig","year":"2006","journal-title":"Cell Microbiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1099\/vir.0.061242-0","article-title":"Raf\/MEK\/ERK pathway activation is required for Jun\u00edn virus replication","volume":"95","author":"Brunetti","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/BJ20031375","article-title":"The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication","volume":"381","author":"Andrade","year":"2004","journal-title":"Biochem. J."},{"key":"ref_105","unstructured":"ClinicalTrials.gov (2023, February 02). Identifier: NCT00404248. Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients with Recurrent High-Grade Glioma, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00404248."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Le Sommer, C., Barrows, N.J., Bradrick, S.S., Pearson, J.L., and Garcia-Blanco, M.A. (2012). G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001820"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"32426","DOI":"10.1074\/jbc.M313137200","article-title":"The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1","volume":"279","author":"Hemonnot","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1073\/pnas.0611681104","article-title":"c-Src protein kinase inhibitors block assembly and maturation of dengue virus","volume":"104","author":"Chu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1128\/JVI.79.18.11943-11951.2005","article-title":"The Src family kinase c-Yes is required for maturation of West Nile virus particles","volume":"79","author":"Hirsch","year":"2005","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/JVI.01969-10","article-title":"Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"11914","DOI":"10.1128\/JVI.79.18.11914-11924.2005","article-title":"The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro","volume":"79","author":"Zhen","year":"2005","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Purcaru, O.S., Artene, S.A., Barcan, E., Silosi, C.A., Stanciu, I., Danoiu, S., Tudorache, S., Tataranu, L.G., and Dricu, A. (2021). The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094830"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_114","unstructured":"(2022, December 08). GeneCards-The Human Gene Database. KRR1 Gene\u2014KRR1 Small Subunit Processome Component Homolog. Available online: https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=KRR1."},{"key":"ref_115","unstructured":"(2022, December 09). National Library of Medicine\u2014National Center for Biotechnology Information. KRR1 Small Subunit Processome Component Homolog [Homo Sapiens (Human)], Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene\/11103."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.273.5281.1547","article-title":"Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex","volume":"273","author":"Battiste","year":"1996","journal-title":"Science"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0092-8674(93)90280-4","article-title":"RNA recognition by an isolated alpha helix","volume":"73","author":"Tan","year":"1993","journal-title":"Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/338254a0","article-title":"The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA","volume":"338","author":"Malim","year":"1989","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(90)90671-Z","article-title":"HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region","volume":"60","author":"Heaphy","year":"1990","journal-title":"Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"50167","DOI":"10.1074\/jbc.M407713200","article-title":"In vivo HIV-1 Rev multimerization in the nucleolus and cytoplasm identified by fluorescence resonance energy transfer","volume":"279","author":"Daelemans","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/jvi.63.9.3708-3713.1989","article-title":"Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression","volume":"63","author":"Kim","year":"1989","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1073\/pnas.88.11.5011","article-title":"Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes","volume":"88","author":"Klotman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1089\/aid.2017.0306","article-title":"Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles","volume":"34","author":"Arizala","year":"2018","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"664353","DOI":"10.3389\/fmicb.2021.664353","article-title":"RIPK3-Dependent Necroptosis Limits PRV Replication in PK-15 Cells","volume":"12","author":"Gou","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41418-018-0172-x","article-title":"Necroptosis in anti-viral inflammation","volume":"26","author":"Nailwal","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/cdd.2014.77","article-title":"Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis","volume":"21","author":"Wu","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.coviro.2013.05.019","article-title":"Viral modulation of programmed necrosis","volume":"3","author":"Kaiser","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.chom.2016.09.014","article-title":"DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death","volume":"20","author":"Thapa","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/cdd.2016.153","article-title":"Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway","volume":"24","author":"Schock","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","article-title":"DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA","volume":"11","author":"Upton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.chom.2015.01.003","article-title":"Herpes simplex virus suppresses necroptosis in human cells","volume":"17","author":"Guo","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Hunter","year":"2001","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/jvi.62.3.1080-1083.1988","article-title":"Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum","volume":"62","author":"Chang","year":"1988","journal-title":"J. Virol."},{"key":"ref_139","first-page":"332","article-title":"Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors","volume":"6","author":"King","year":"1986","journal-title":"Mol. Cell Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1073\/pnas.82.16.5300","article-title":"Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors","volume":"82","author":"Twardzik","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0092-8674(85)80133-1","article-title":"Purification and characterization of vaccinia virus growth factor","volume":"42","author":"Stroobant","year":"1985","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/JVI.72.2.1235-1243.1998","article-title":"Virus-induced cell motility","volume":"72","author":"Sanderson","year":"1998","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41564-018-0288-2","article-title":"Vaccinia virus hijacks EGFR signalling to enhance virus spread through rapid and directed infected cell motility","volume":"4","author":"Beerli","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2010.11.006","article-title":"Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa)","volume":"89","author":"Langhammer","year":"2011","journal-title":"Antiviral Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"elife"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.20121401","article-title":"Respiratory virus\u2013induced EGFR activation suppresses IRF1-dependent interferon \u03bb and antiviral defense in airway epithelium","volume":"210","author":"Ueki","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"40760","DOI":"10.1038\/srep40760","article-title":"Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Currier, M.G., Lee, S., Stobart, C.C., Hotard, A.L., Villenave, R., Meng, J., Pretto, C.D., Shields, M.D., Nguyen, M.T., and Todd, S.O. (2016). EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005622"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrmicro3469","article-title":"Viral apoptotic mimicry","volume":"13","author":"Amara","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12964-019-0452-1","article-title":"Roles of phosphatidylserine exposed on the viral envelope and cell membrane in HIV-1 replication","volume":"17","author":"Chua","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","article-title":"TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity","volume":"235","author":"Freeman","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e02079-20","DOI":"10.1128\/JVI.02079-20","article-title":"Phosphatidylethanolamine and Phosphatidylserine Synergize To Enhance GAS6\/AXL-Mediated Virus Infection and Efferocytosis","volume":"95","author":"Zhang","year":"2020","journal-title":"J. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK\u2013STAT signaling: Lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front. immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0092-8674(90)90182-E","article-title":"Shared architecture of hormone binding domains in type I and II interferon receptors","volume":"61","author":"Bazan","year":"1990","journal-title":"Cell"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The molecular regulation of Janus kinase (JAK) activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem. J."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/JVI.02188-08","article-title":"NS5 of dengue virus mediates STAT2 binding and degradation","volume":"83","author":"Ashour","year":"2009","journal-title":"J. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e00856-20","DOI":"10.1128\/JVI.00856-20","article-title":"The dynamic interface of viruses with STATs","volume":"94","author":"Harrison","year":"2020","journal-title":"J. Virol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1753425918803674","article-title":"HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation","volume":"24","author":"Nguyen","year":"2018","journal-title":"Innate Immun."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): A randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"720697","DOI":"10.3389\/fimmu.2021.720697","article-title":"The Effect of JAK1\/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency","volume":"12","author":"Gavegnano","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chom.2013.07.005","article-title":"Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors","volume":"14","author":"Bhattacharyya","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1073\/pnas.1614926114","article-title":"GAS6 is a key homeostatic immunological regulator of host\u2013commensal interactions in the oral mucosa","volume":"114","author":"Nassar","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.celrep.2020.02.101","article-title":"Dead cells induce innate anergy via mertk after acute viral infection","volume":"30","author":"Adomati","year":"2020","journal-title":"Cell Rep."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/22221751.2020.1738278","article-title":"MERTK is a host factor that promotes classical swine fever virus entry and antagonizes innate immune response in PK-15 cells","volume":"9","author":"Zheng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Neveu, G., Barouch-Bentov, R., Ziv-Av, A., Gerber, D., Jacob, Y., and Einav, S. (2012). Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002845"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/jm501759m","article-title":"Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents","volume":"58","author":"Kovackova","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","article-title":"Virus entry by endocytosis","volume":"79","author":"Mercer","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-777X.176140","article-title":"The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG)","volume":"8","author":"Sikka","year":"2016","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1128\/JVI.00815-13","article-title":"Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis","volume":"87","author":"Sloan","year":"2013","journal-title":"J. Virol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2018.11.065","article-title":"Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo [4,3-b]pyridines","volume":"163","author":"Wouters","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acs.jmedchem.8b00613","article-title":"Optimization of Isothiazolo [4,3-b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity","volume":"61","author":"Pu","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"115188","DOI":"10.1016\/j.bmc.2019.115188","article-title":"Structure-activity relationship study of the pyridine moiety of isothiazolo [4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase","volume":"28","author":"Pu","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1039\/C5MD00229J","article-title":"Isothiazolo [4,3-b]pyridines as inhibitors of cyclin G associated kinase: Synthesis, structure-activity relationship studies and antiviral activity","volume":"6","author":"Li","year":"2015","journal-title":"Medchemcomm"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuroscience.2006.01.017","article-title":"Anatomical localization of leucine-rich repeat kinase 2 in mouse brain","volume":"139","author":"Melrose","year":"2006","journal-title":"Neuroscience"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5483\/BMBRep.2010.43.4.233","article-title":"Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson\u2019s disease","volume":"43","author":"Seol","year":"2010","journal-title":"BMB Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jnr.21949","article-title":"Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson\u2019s disease","volume":"87","author":"Gandhi","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7196\/SAMJ.6677","article-title":"HIV-associated neurocognitive disorders: Antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes","volume":"103","author":"Cross","year":"2013","journal-title":"S. Afr. Med. J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"18506","DOI":"10.7448\/IAS.16.1.18506","article-title":"\u201cMy body\u2019s a 50 year-old but my brain is definitely an 85 year-old\u201d: Exploring the experiences of men ageing with HIV-associated neurocognitive challenges","volume":"16","author":"Hopcroft","year":"2013","journal-title":"J. Int. AIDS Soc."},{"key":"ref_185","first-page":"1085","article-title":"Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method","volume":"136","author":"Kure","year":"1990","journal-title":"Am. J. Pathol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00126334-200210012-00004","article-title":"HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes","volume":"31","author":"Anderson","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1523\/JNEUROSCI.0650-14.2015","article-title":"Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders","volume":"35","author":"Puccini","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson\u2019s disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1742-2094-9-261","article-title":"LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein","volume":"9","author":"Marker","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cyto.2015.02.025","article-title":"Toll-like receptors: Activation, signalling and transcriptional modulation","volume":"74","year":"2015","journal-title":"Cytokine"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.M109.022392","article-title":"An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4","volume":"284","author":"Motshwene","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature09121","article-title":"Helical assembly in the MyD88\u2013IRAK4\u2013IRAK2 complex in TLR\/IL-1R signalling","volume":"465","author":"Lin","year":"2010","journal-title":"Nature"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1073\/pnas.1714386114","article-title":"Crystal structure of human IRAK1","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ni.1606","article-title":"Sequential control of Toll-like receptor\u2013dependent responses by IRAK1 and IRAK2","volume":"9","author":"Kawagoe","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.molcel.2014.08.006","article-title":"IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly","volume":"55","author":"Ferrao","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature00888","article-title":"Distinct molecular mechanism for initiating TRAF6 signalling","volume":"418","author":"Ye","year":"2002","journal-title":"Nature"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"41661","DOI":"10.1074\/jbc.M102262200","article-title":"IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NF\u03baB","volume":"276","author":"Qian","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng0804-790","article-title":"TGF\u03b2 signaling in health and disease","volume":"36","author":"Akhurst","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/sj.onc.1210741","article-title":"Sustained TGF\u03b2 exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis","volume":"27","author":"Gal","year":"2008","journal-title":"Oncogene"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.onc.1210202","article-title":"The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer","volume":"26","author":"Dillon","year":"2007","journal-title":"Oncogene"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","article-title":"Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism","volume":"92","author":"Datto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1073\/pnas.0932636100","article-title":"Transforming growth factor \u03b2 signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis","volume":"100","author":"Siegel","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Harmon, B., Campbell, N., and Ratner, L. (2010). Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000956"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcp.2016.02.002","article-title":"Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells","volume":"106","author":"Bermejo","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","article-title":"Defective B cell development and function in Btk-deficient mice","volume":"3","author":"Khan","year":"1995","journal-title":"Immunity"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1111\/jcmm.14548","article-title":"Effects of BTK signalling in pathogenic microorganism infections","volume":"23","author":"Ye","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbrc.2018.03.140","article-title":"Bruton\u2019s tyrosine kinase regulates TLR7\/8-induced TNF transcription via nuclear factor-\u03baB recruitment","volume":"499","author":"Page","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1128\/JVI.80.9.4422-4430.2006","article-title":"Negative regulation of the alpha interferon-induced antiviral response by the Ras\/Raf\/MEK pathway","volume":"80","author":"Battcock","year":"2006","journal-title":"J. Virol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"Ludwig","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1128\/JVI.02193-07","article-title":"Suppression of astrovirus replication by an ERK1\/2 inhibitor","volume":"82","author":"Moser","year":"2008","journal-title":"J. Virol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000511280","article-title":"SARS-CoV-2 and the possible role of Raf\/MEK\/ERK pathway in viral survival: Is this a potential therapeutic strategy for COVID-19?","volume":"106","author":"Pashapour","year":"2021","journal-title":"Pharmacology"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00705-021-05103-0","article-title":"Protective effects of SP600125 on mice infected with H1N1 influenza A virus","volume":"166","author":"Tang","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2011.10.020","article-title":"SP600125 inhibits Orthopoxviruses replication in a JNK1\/2 -independent manner: Implication as a potential antipoxviral","volume":"93","author":"Pereira","year":"2012","journal-title":"Antiviral Res."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2017.02.003","article-title":"JNK1\/2 inhibitor reduces dengue virus-induced liver injury","volume":"141","author":"Sreekanth","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2018.11.014","article-title":"Inhibition of fowl adenovirus serotype 4 replication in Leghorn male hepatoma cells by SP600125 via blocking JNK MAPK pathway","volume":"228","author":"He","year":"2019","journal-title":"Vet. Microbiol."},{"key":"ref_218","first-page":"22","article-title":"The role of SARS-CoV protein, ORF-6, in the induction of host cell death","volume":"16","author":"Ye","year":"2010","journal-title":"Hong Kong Med. J."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"103696","DOI":"10.1016\/j.jbi.2021.103696","article-title":"Drug repurposing for COVID-19 via knowledge graph completion","volume":"115","author":"Zhang","year":"2021","journal-title":"J. Biomed. Inform."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2004.05.107","article-title":"Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells","volume":"319","author":"Mizutani","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00705-021-05021-1","article-title":"Evaluation of kinase inhibitors as potential therapeutics for flavivirus infections","volume":"166","author":"Valencia","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","article-title":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","volume":"157","author":"Dudek","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.18632\/oncotarget.27799","article-title":"MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection","volume":"11","author":"Zhou","year":"2020","journal-title":"Oncotarget"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1038\/s41598-021-84044-9","article-title":"Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach","volume":"11","author":"Imami","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.csbj.2020.11.054","article-title":"L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies","volume":"18","author":"Sendama","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"18811","DOI":"10.1038\/s41598-022-21984-w","article-title":"Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses","volume":"12","author":"Shen","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Aggarwal, M., Leser, G.P., and Lamb, R.A. (2020). Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses. J. Virol., 94.","DOI":"10.1128\/JVI.01888-19"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/ptr.7442","article-title":"The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review","volume":"36","author":"Gonzalez","year":"2022","journal-title":"Phytother. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41597-021-00848-4","article-title":"A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection","volume":"8","author":"Ellinger","year":"2021","journal-title":"Sci. Data"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ddr.21961","article-title":"Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs)","volume":"83","author":"Valipour","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"104806","DOI":"10.1016\/j.antiviral.2020.104806","article-title":"Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model","volume":"178","author":"Laure","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Schreiber, A., Ambrosy, B., Planz, O., Schloer, S., Rescher, U., and Ludwig, S. (2022). The MEK1\/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091776"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00018-021-04085-1","article-title":"The MEK1\/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine\/chemokine responses","volume":"79","author":"Schreiber","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"611958","DOI":"10.3389\/fmicb.2021.611958","article-title":"Improved in vitro Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002","volume":"12","author":"Hamza","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1038\/s41598-018-27445-7","article-title":"Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound","volume":"8","author":"Bruchhagen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer","volume":"373","author":"Turner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and Letrozole in Advanced Breast Cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-16-3157","article-title":"Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4\/6 Inhibitor in Various Solid Tumors","volume":"23","author":"Tripathy","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.18632\/oncotarget.27407","article-title":"Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models","volume":"11","author":"Kim","year":"2020","journal-title":"Oncotarget"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/tbj.14204","article-title":"COVID-19 risk in breast cancer patients receiving CDK4\/6 inhibitors: Literature data and a monocentric experience","volume":"27","author":"Barba","year":"2021","journal-title":"Breast J."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","article-title":"MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40265-020-01461-2","article-title":"Inhibiting CDK4\/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences","volume":"81","author":"Braal","year":"2021","journal-title":"Drugs"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkv363","article-title":"Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1","volume":"71","author":"Badia","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/QAD.0000000000000399","article-title":"Palbociclib, a selective inhibitor of cyclin-dependent kinase4\/6, blocks HIV-1 reverse transcription through the control of sterile \u03b1 motif and HD domain-containing protein-1 (SAMHD1) activity","volume":"28","author":"Pauls","year":"2014","journal-title":"AIDS"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"28345","DOI":"10.1074\/jbc.C000446200","article-title":"Flavopiridol inhibits P-TEFb and blocks HIV-1 replication","volume":"275","author":"Chao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1742-4690-4-47","article-title":"Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex","volume":"4","author":"Biglione","year":"2007","journal-title":"Retrovirology"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/cbic.200900303","article-title":"Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication","volume":"10","author":"Ali","year":"2009","journal-title":"Chembiochem"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/cas.14241","article-title":"Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders","volume":"111","author":"Watanabe","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI73805","article-title":"CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses","volume":"124","author":"Yamamoto","year":"2014","journal-title":"J. Clin. Invest."},{"key":"ref_251","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The Global Phosphorylation Landscape of SARS-CoV-2 Infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Eierhoff, T., Hrincius, E.R., Rescher, U., Ludwig, S., and Ehrhardt, C. (2010). The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001099"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virusres.2006.09.004","article-title":"The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages","volume":"123","author":"Stantchev","year":"2007","journal-title":"Virus Res."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF01309554","article-title":"Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase","volume":"132","author":"Yura","year":"1993","journal-title":"Arch. Virol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jnutbio.2009.04.004","article-title":"Soy isoflavones and virus infections","volume":"20","author":"Andres","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17512433.2021.1903317","article-title":"Compounds of plants with activity against SARS-CoV-2 targets","volume":"14","author":"Marmitt","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"961154","DOI":"10.3389\/fphar.2022.961154","article-title":"Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"102511","DOI":"10.1016\/j.jbc.2022.102511","article-title":"SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike-mediated cell-to-cell fusion","volume":"298","author":"Zhang","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","article-title":"The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis","volume":"143","author":"Venkataraman","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2394-5079.158391","article-title":"Sorafenib suppresses hepatitis B virus gene expression via inhibiting JNK pathway","volume":"1","author":"Cho","year":"2015","journal-title":"Hepatoma Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1038\/s41467-021-25796-w","article-title":"Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential","volume":"12","author":"Meyer","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cell.2021.02.008","article-title":"In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.str.2015.12.015","article-title":"Family-wide Structural Analysis of Human Numb-Associated Protein Kinases","volume":"24","author":"Sorrell","year":"2016","journal-title":"Structure"},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Shin, J.S., Jung, E., Kim, M., Baric, R.S., and Go, Y.Y. (2018). Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro. Viruses, 10.","DOI":"10.3390\/v10060283"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41421-020-00217-2","article-title":"Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"105967","DOI":"10.1016\/j.ijantimicag.2020.105967","article-title":"Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19","volume":"55","author":"Praveen","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.00632-13","article-title":"The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase","volume":"87","author":"LaCroix","year":"2013","journal-title":"J. Virol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41401-020-00556-6","article-title":"Identification of SARS-CoV-2 entry inhibitors among already approved drugs","volume":"42","author":"Yang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"104866","DOI":"10.1016\/j.phrs.2020.104866","article-title":"The CoV-2 outbreak: How hematologists could help to fight Covid-19","volume":"157","author":"Galimberti","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"e202100248","DOI":"10.1002\/open.202100248","article-title":"Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach","volume":"11","author":"Sencanski","year":"2022","journal-title":"ChemistryOpen"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e10426","DOI":"10.15252\/msb.202110426","article-title":"Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release","volume":"17","author":"Chan","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"31935","DOI":"10.1021\/acsomega.2c02794","article-title":"Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice","volume":"7","author":"Puhl","year":"2022","journal-title":"ACS Omega"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JVI.02514-12","article-title":"SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells","volume":"87","author":"Casartelli","year":"2013","journal-title":"J. Virol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/1078155220953198","article-title":"Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors","volume":"26","author":"Ata","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Nelson, E.A., Dyall, J., Hoenen, T., Barnes, A.B., Zhou, H., Liang, J.Y., Michelotti, J., Dewey, W.H., DeWald, L.E., and Bennett, R.S. (2017). The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005540"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"20803","DOI":"10.1073\/pnas.2007837117","article-title":"Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2","volume":"117","author":"Kang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-022-01025-8","article-title":"PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron","volume":"7","author":"Su","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_284","first-page":"68","article-title":"Imatinib a Tyrosine Kinase Inhibitor: A potential treatment for SARS-COV-2 induced pneumonia","volume":"56","author":"Assaad","year":"2020","journal-title":"Alex. J. Med."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein","volume":"23","author":"Clark","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors","volume":"99","author":"Sisk","year":"2018","journal-title":"J. Gen. Virol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5114\/aoms.2020.94504","article-title":"Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2","volume":"16","author":"Nabavi","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2019.05.033","article-title":"CaM Kinase: Still Inspiring at 40","volume":"103","author":"Bayer","year":"2019","journal-title":"Neuron"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fphar.2014.00021","article-title":"CaMKII inhibitors: From research tools to therapeutic agents","volume":"5","author":"Pellicena","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/acs.jmedchem.9b01779","article-title":"Benzenesulfonamide Derivatives as Calcium\/Calmodulin-Dependent Protein Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus Infections","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.18632\/oncotarget.2158","article-title":"Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970","volume":"5","author":"Hall","year":"2014","journal-title":"Oncotarget"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"108940","DOI":"10.1016\/j.celrep.2021.108940","article-title":"Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication","volume":"35","author":"Garcia","year":"2021","journal-title":"Cell Rep."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/rmv.687","article-title":"Viruses and the fuel sensor: The emerging link between AMPK and virus replication","volume":"21","author":"Mankouri","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/JVI.01634-12","article-title":"AMP-Activated Protein Kinase Is Required for the Macropinocytic Internalization of Ebolavirus","volume":"87","author":"Kondratowicz","year":"2013","journal-title":"Virol. J."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2901-9","article-title":"Identification of SARS-CoV-2 inhibitors using lung and colonic organoids","volume":"589","author":"Han","year":"2021","journal-title":"Nature"},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Saeed, M.F., Kolokoltsov, A.A., Freiberg, A.N., Holbrook, M.R., and Davey, R.A. (2008). Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000141"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1099\/vir.0.024166-0","article-title":"Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry","volume":"91","author":"Tiwari","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez, E.G., Quintas, A., P\u00e9rez-N\u00fa\u00f1ez, D., Nogal, M., Barroso, S., Carrascosa, \u00c1.L., and Revilla, Y. (2012). African swine fever virus uses macropinocytosis to enter host cells. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002754"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"McGowan, E.M., Haddadi, N., Nassif, N.T., and Lin, Y. (2020). Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197189"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acs.jmedchem.0c01467","article-title":"Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections","volume":"65","author":"Raghuvanshi","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acs.jmedchem.1c00335","article-title":"Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy","volume":"65","author":"Pillaiyar","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: Progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2174\/1568026615666150915115823","article-title":"Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors","volume":"16","author":"Sabbah","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.2174\/092986711798347298","article-title":"Dual inhibitors of PI3K\/mTOR or mTOR-selective inhibitors: Which way shall we go?","volume":"18","author":"Sabbah","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"A.4H.1","DOI":"10.1002\/9780471729259.mca04hs17","article-title":"Growth and maintenance of baby hamster kidney (BHK) cells","volume":"17","author":"Hernandez","year":"2010","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"A.4E.1","DOI":"10.1002\/9780471729259.mca04es11","article-title":"Growth and maintenance of Vero cell lines","volume":"11","author":"Ammerman","year":"2008","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/AAC.00303-13","article-title":"Phosphatidylinositol 4-Kinase III Beta Is Essential for Replication of Human Rhinovirus and Its Inhibition Causes a Lethal Phenotype In Vivo","volume":"57","author":"Spickler","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"116356","DOI":"10.1016\/j.bmc.2021.116356","article-title":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","volume":"46","author":"Mahajan","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: The example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-020-02476-9","article-title":"A painful lesson from the COVID-19 pandemic: The need for broad-spectrum, host-directed antivirals","volume":"18","author":"Chitalia","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2014.02.008","article-title":"What are the pros and cons of the use of host-targeted agents against hepatitis C?","volume":"105","author":"Pawlotsky","year":"2014","journal-title":"Antiviral Res."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.27960","article-title":"Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"Hepatology"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/C4NP00085D","article-title":"Antiviral drug discovery: Broad-spectrum drugs from nature","volume":"32","author":"Martinez","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1572-0241.2008.01876.x","article-title":"Fluvastatin inhibits hepatitis C replication in humans","volume":"103","author":"Bader","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000213504","article-title":"An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads","volume":"52","author":"Sezaki","year":"2009","journal-title":"Intervirology"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"120809","DOI":"10.1016\/j.lfs.2022.120809","article-title":"Recent clinical findings on the role of kinase inhibitors in COVID-19 management","volume":"306","author":"Malekinejad","year":"2022","journal-title":"Life Sci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cbic.200400393","article-title":"Small-molecule kinase-inhibitor target assessment","volume":"6","author":"Kung","year":"2005","journal-title":"Chembiochem"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nmeth931","article-title":"State-based discovery: A multidimensional screen for small-molecule modulators of EGF signaling","volume":"3","author":"Sevecka","year":"2006","journal-title":"Nat. Methods"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.107.035113","article-title":"Building a pharmacological lexicon: Small molecule discovery in academia","volume":"72","author":"Lazo","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ncb1418","article-title":"A global analysis of cross-talk in a mammalian cellular signalling network","volume":"8","author":"Natarajan","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Ventura, A.C., Sepulchre, J.A., and Merajver, S.D. (2008). A hidden feedback in signaling cascades is revealed. PLoS Comput. Biol., 4.","DOI":"10.1371\/journal.pcbi.1000041"},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Wynn, M.L., Ventura, A.C., Sepulchre, J.A., Garc\u00eda, H.J., and Merajver, S.D. (2011). Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity. BMC Syst. Biol., 5.","DOI":"10.1186\/1752-0509-5-156"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1126\/science.1116598","article-title":"A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis","volume":"310","author":"Janes","year":"2005","journal-title":"Science"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nature06001","article-title":"Common effector processing mediates cell-specific responses to stimuli","volume":"448","author":"Janes","year":"2007","journal-title":"Nature"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.178.8.4984","article-title":"Quantitative network signal combinations downstream of TCR activation can predict IL-2 production response","volume":"178","author":"Kemp","year":"2007","journal-title":"J. Immunol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10409238.2016.1215406","article-title":"Oligomeric viral proteins: Small in size, large in presence","volume":"51","author":"Jayaraman","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2020.07.001","article-title":"Viral structural proteins as targets for antivirals","volume":"45","author":"Schlicksup","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"14365","DOI":"10.1073\/pnas.0804461105","article-title":"Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element","volume":"105","author":"Legiewicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cld.2010.05.004","article-title":"Drug resistance in antiviral therapy","volume":"14","author":"Locarnini","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fgene.2019.00696","article-title":"Host Genetic Determinants of Hepatitis B Virus Infection","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Genet."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/568\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:36:22Z","timestamp":1760121382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,19]]},"references-count":335,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["v15020568"],"URL":"https:\/\/doi.org\/10.3390\/v15020568","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,19]]}}}